Discovery and Development of GS 4104 (oseltamivir) An Orally Active Influenza Neuraminidase Inhibitor

E-ISSN： 1875-533x|7|6|663-672

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.7, Iss.6, 2000-06, pp. : 663-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oseltamivir/zanamivir: Development of neuraminidase inhibitor resistance in influenza A virus H1N1 subtype in a child: case report

Reactions Weekly, Vol. 1, Iss. 1326, 2010-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite

Different Synthetic Strategies of Oseltamivir Phosphate: A Potent Influenza Neuraminidase Inhibitor

Current Medicinal Chemistry, Vol. 15, Iss. 30, 2008-12 ,pp. : 3145-3159

Bentham Science Publishers

Access to resources Recommend Favorite

A novel orally active inhibitor of HLE

By Varga M. Kapui Z. Batori S. Nagy L.T. Vasvari-Debreczy L. Mikus E. Urban-Szabo K. Aranyi P.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 421-425

Elsevier

Access to resources Recommend Favorite

Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses

By Hurt Aeron C. Holien Jessica K. Parker Michael W. Barr Ian G.

Drugs, Vol. 69, Iss. 18, 2009-12 ,pp. : 2523-2531

Adis International

Access to resources Recommend Favorite

Neuraminidase inhibitor RWJ 270201 prepares to compete in influenza market

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite